Certain subsets of immune NK cells were altered in the blood of people with ALS, and could serve as therapeutic targets, a ...
Medigene AG (Medigene, FSE: MDG1, Prime Standard), an oncology platform company focused on the research and development of T cell receptor ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback